Blood Donation Clinical Trial
Official title:
Blood Donor Recruitment During Epidemic of COVID-19 in Guangzhou, China
Verified date | April 2020 |
Source | Guangzhou Blood Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In December 2019, an unknown pneumonia rapidly spread in Wuhan, China, a new coronavirus, 2019 novel coronavirus (2019-nCoV), aroused the attention of the entire world. On January 31, 2020, World Health Organization (WHO) announced the outbreak of Coronavirus Disease 2019 (COVID-19) in China as a Public Health Emergency of International Concern. The number of volunteer non-remunerated blood donors decreased because of quarantine, caring for relatives, and fear of exposure to COVID-19. Due to the blood shortage, patient blood management and cessation of elective surgery are contributing to decreased demand, but sepsis may increase requirements and significant reductions will not be possible in areas such as trauma, cancer patients, hereditary haemolytic anaemias and childbirth. Therefore, recruiting enough blood donors during the epidemic is vital for public health in China, and also worldwide. In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not. The questionnaires were randomly sent to ever blood donors, and the same number of ever blood donors are coded as control.
Status | Completed |
Enrollment | 19491 |
Est. completion date | April 3, 2020 |
Est. primary completion date | March 13, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Blood donors whose last donation were between 1 Feb to 31 March, 2019. Exclusion Criteria: - Blood donors whose blood test results were positive. Blood donors who were aged above 60. Blood donors whose cell phone number was obviously invalid. |
Country | Name | City | State |
---|---|---|---|
China | Guangzhou Blood Center | Guangzhou | Guangdong |
Lead Sponsor | Collaborator |
---|---|
Guangzhou Blood Center |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Differences of attitude about blood donation towards different questionnaires | Compare participants' intention of blood donation after they read different information in the questionnaire. | 1 day | |
Secondary | Rates of blood donation during 3 weeks | Blood donation rate of 3 groups will be followed | 3 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05791968 -
Blood Donation Could Improve Insulin Sensitivity
|
N/A | |
Recruiting |
NCT02281565 -
Attitudes About Blood Donation
|
N/A | |
Enrolling by invitation |
NCT04410458 -
Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial)
|
N/A | |
Active, not recruiting |
NCT01610635 -
INTERVAL Study: To Determine Whether the Interval Between Blood Donations in England Can be Safely and Acceptably Decreased
|
N/A | |
Enrolling by invitation |
NCT04431180 -
Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#
|
N/A | |
Recruiting |
NCT04484896 -
Message Framing on Recruiting Rh-D Negative Blood Donors
|
N/A | |
Active, not recruiting |
NCT05678647 -
Sucrosomial Iron and Iron Sulphate to Blood Donors
|
N/A | |
Completed |
NCT05319951 -
Effect of Different Liquids Intake in Vasovagal Reaction After Whole Blood Donation
|
N/A | |
Completed |
NCT05213130 -
Blood Donation and Subjective Well-being
|
N/A | |
Completed |
NCT00023023 -
Study of Transfusion-Transmitted Infections
|
||
Recruiting |
NCT06101238 -
BLOODSAFE Ghana- Iron and Nutritional Counselling Strategy
|
N/A | |
Enrolling by invitation |
NCT06138899 -
Enhancing Blood Donation at Schools and Beyond in Malawi
|
N/A | |
Completed |
NCT04370886 -
Recruit Blood Donors Via SMS During Epidemic of COVID-19
|
N/A |